Injectable Targeted Therapy Market - Global Outlook and Forecast 2023-2028

Report ID: 1365638 | Published Date: Oct 2024 | No. of Page: 63 | Base Year: 2023 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Injectable Targeted Therapy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Injectable Targeted Therapy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Injectable Targeted Therapy Overall Market Size
    2.1 Global Injectable Targeted Therapy Market Size: 2021 VS 2028
    2.2 Global Injectable Targeted Therapy Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Injectable Targeted Therapy Players in Global Market
    3.2 Top Global Injectable Targeted Therapy Companies Ranked by Revenue
    3.3 Global Injectable Targeted Therapy Revenue by Companies
    3.4 Top 3 and Top 5 Injectable Targeted Therapy Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Injectable Targeted Therapy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Injectable Targeted Therapy Players in Global Market
        3.6.1 List of Global Tier 1 Injectable Targeted Therapy Companies
        3.6.2 List of Global Tier 2 and Tier 3 Injectable Targeted Therapy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Injectable Targeted Therapy Market Size Markets, 2021 & 2028
        4.1.2 Monoclonal Antibodies
        4.1.3 Small-Molecules
        4.1.4 Immunotoxins
        4.1.5 Others
    4.2 By Type - Global Injectable Targeted Therapy Revenue & Forecasts
        4.2.1 By Type - Global Injectable Targeted Therapy Revenue, 2017-2022
        4.2.2 By Type - Global Injectable Targeted Therapy Revenue, 2023-2028
        4.2.3 By Type - Global Injectable Targeted Therapy Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Injectable Targeted Therapy Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Homecare
        5.1.4 Specialty Clinics
        5.1.5 Others
    5.2 By Application - Global Injectable Targeted Therapy Revenue & Forecasts
        5.2.1 By Application - Global Injectable Targeted Therapy Revenue, 2017-2022
        5.2.2 By Application - Global Injectable Targeted Therapy Revenue, 2023-2028
        5.2.3 By Application - Global Injectable Targeted Therapy Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Injectable Targeted Therapy Market Size, 2021 & 2028
    6.2 By Region - Global Injectable Targeted Therapy Revenue & Forecasts
        6.2.1 By Region - Global Injectable Targeted Therapy Revenue, 2017-2022
        6.2.2 By Region - Global Injectable Targeted Therapy Revenue, 2023-2028
        6.2.3 By Region - Global Injectable Targeted Therapy Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Injectable Targeted Therapy Revenue, 2017-2028
        6.3.2 US Injectable Targeted Therapy Market Size, 2017-2028
        6.3.3 Canada Injectable Targeted Therapy Market Size, 2017-2028
        6.3.4 Mexico Injectable Targeted Therapy Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Injectable Targeted Therapy Revenue, 2017-2028
        6.4.2 Germany Injectable Targeted Therapy Market Size, 2017-2028
        6.4.3 France Injectable Targeted Therapy Market Size, 2017-2028
        6.4.4 U.K. Injectable Targeted Therapy Market Size, 2017-2028
        6.4.5 Italy Injectable Targeted Therapy Market Size, 2017-2028
        6.4.6 Russia Injectable Targeted Therapy Market Size, 2017-2028
        6.4.7 Nordic Countries Injectable Targeted Therapy Market Size, 2017-2028
        6.4.8 Benelux Injectable Targeted Therapy Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Injectable Targeted Therapy Revenue, 2017-2028
        6.5.2 China Injectable Targeted Therapy Market Size, 2017-2028
        6.5.3 Japan Injectable Targeted Therapy Market Size, 2017-2028
        6.5.4 South Korea Injectable Targeted Therapy Market Size, 2017-2028
        6.5.5 Southeast Asia Injectable Targeted Therapy Market Size, 2017-2028
        6.5.6 India Injectable Targeted Therapy Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Injectable Targeted Therapy Revenue, 2017-2028
        6.6.2 Brazil Injectable Targeted Therapy Market Size, 2017-2028
        6.6.3 Argentina Injectable Targeted Therapy Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Injectable Targeted Therapy Revenue, 2017-2028
        6.7.2 Turkey Injectable Targeted Therapy Market Size, 2017-2028
        6.7.3 Israel Injectable Targeted Therapy Market Size, 2017-2028
        6.7.4 Saudi Arabia Injectable Targeted Therapy Market Size, 2017-2028
        6.7.5 UAE Injectable Targeted Therapy Market Size, 2017-2028
7 Players Profiles
    7.1 Novartis
        7.1.1 Novartis Corporate Summary
        7.1.2 Novartis Business Overview
        7.1.3 Novartis Injectable Targeted Therapy Major Product Offerings
        7.1.4 Novartis Injectable Targeted Therapy Revenue in Global Market (2017-2022)
        7.1.5 Novartis Key News
    7.2 Sanofi
        7.2.1 Sanofi Corporate Summary
        7.2.2 Sanofi Business Overview
        7.2.3 Sanofi Injectable Targeted Therapy Major Product Offerings
        7.2.4 Sanofi Injectable Targeted Therapy Revenue in Global Market (2017-2022)
        7.2.5 Sanofi Key News
    7.3 GSK
        7.3.1 GSK Corporate Summary
        7.3.2 GSK Business Overview
        7.3.3 GSK Injectable Targeted Therapy Major Product Offerings
        7.3.4 GSK Injectable Targeted Therapy Revenue in Global Market (2017-2022)
        7.3.5 GSK Key News
    7.4 Bayer
        7.4.1 Bayer Corporate Summary
        7.4.2 Bayer Business Overview
        7.4.3 Bayer Injectable Targeted Therapy Major Product Offerings
        7.4.4 Bayer Injectable Targeted Therapy Revenue in Global Market (2017-2022)
        7.4.5 Bayer Key News
    7.5 Amgen
        7.5.1 Amgen Corporate Summary
        7.5.2 Amgen Business Overview
        7.5.3 Amgen Injectable Targeted Therapy Major Product Offerings
        7.5.4 Amgen Injectable Targeted Therapy Revenue in Global Market (2017-2022)
        7.5.5 Amgen Key News
    7.6 Merck
        7.6.1 Merck Corporate Summary
        7.6.2 Merck Business Overview
        7.6.3 Merck Injectable Targeted Therapy Major Product Offerings
        7.6.4 Merck Injectable Targeted Therapy Revenue in Global Market (2017-2022)
        7.6.5 Merck Key News
    7.7 AbbiVie
        7.7.1 AbbiVie Corporate Summary
        7.7.2 AbbiVie Business Overview
        7.7.3 AbbiVie Injectable Targeted Therapy Major Product Offerings
        7.7.4 AbbiVie Injectable Targeted Therapy Revenue in Global Market (2017-2022)
        7.7.5 AbbiVie Key News
    7.8 AstraZeneca
        7.8.1 AstraZeneca Corporate Summary
        7.8.2 AstraZeneca Business Overview
        7.8.3 AstraZeneca Injectable Targeted Therapy Major Product Offerings
        7.8.4 AstraZeneca Injectable Targeted Therapy Revenue in Global Market (2017-2022)
        7.8.5 AstraZeneca Key News
    7.9 Teva
        7.9.1 Teva Corporate Summary
        7.9.2 Teva Business Overview
        7.9.3 Teva Injectable Targeted Therapy Major Product Offerings
        7.9.4 Teva Injectable Targeted Therapy Revenue in Global Market (2017-2022)
        7.9.5 Teva Key News
    7.10 Roche
        7.10.1 Roche Corporate Summary
        7.10.2 Roche Business Overview
        7.10.3 Roche Injectable Targeted Therapy Major Product Offerings
        7.10.4 Roche Injectable Targeted Therapy Revenue in Global Market (2017-2022)
        7.10.5 Roche Key News
    7.11 Pfizer
        7.11.1 Pfizer Corporate Summary
        7.11.2 Pfizer Business Overview
        7.11.3 Pfizer Injectable Targeted Therapy Major Product Offerings
        7.11.4 Pfizer Injectable Targeted Therapy Revenue in Global Market (2017-2022)
        7.11.5 Pfizer Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Injectable Targeted Therapy Market Opportunities & Trends in Global Market
    Table 2. Injectable Targeted Therapy Market Drivers in Global Market
    Table 3. Injectable Targeted Therapy Market Restraints in Global Market
    Table 4. Key Players of Injectable Targeted Therapy in Global Market
    Table 5. Top Injectable Targeted Therapy Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Injectable Targeted Therapy Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Injectable Targeted Therapy Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Injectable Targeted Therapy Product Type
    Table 9. List of Global Tier 1 Injectable Targeted Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Injectable Targeted Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Injectable Targeted Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Injectable Targeted Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Injectable Targeted Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Injectable Targeted Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Injectable Targeted Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Injectable Targeted Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Injectable Targeted Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Injectable Targeted Therapy Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Injectable Targeted Therapy Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Injectable Targeted Therapy Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Injectable Targeted Therapy Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Injectable Targeted Therapy Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Injectable Targeted Therapy Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Injectable Targeted Therapy Revenue, (US$, Mn), 2023-2028
    Table 30. Novartis Corporate Summary
    Table 31. Novartis Injectable Targeted Therapy Product Offerings
    Table 32. Novartis Injectable Targeted Therapy Revenue (US$, Mn), (2017-2022)
    Table 33. Sanofi Corporate Summary
    Table 34. Sanofi Injectable Targeted Therapy Product Offerings
    Table 35. Sanofi Injectable Targeted Therapy Revenue (US$, Mn), (2017-2022)
    Table 36. GSK Corporate Summary
    Table 37. GSK Injectable Targeted Therapy Product Offerings
    Table 38. GSK Injectable Targeted Therapy Revenue (US$, Mn), (2017-2022)
    Table 39. Bayer Corporate Summary
    Table 40. Bayer Injectable Targeted Therapy Product Offerings
    Table 41. Bayer Injectable Targeted Therapy Revenue (US$, Mn), (2017-2022)
    Table 42. Amgen Corporate Summary
    Table 43. Amgen Injectable Targeted Therapy Product Offerings
    Table 44. Amgen Injectable Targeted Therapy Revenue (US$, Mn), (2017-2022)
    Table 45. Merck Corporate Summary
    Table 46. Merck Injectable Targeted Therapy Product Offerings
    Table 47. Merck Injectable Targeted Therapy Revenue (US$, Mn), (2017-2022)
    Table 48. AbbiVie Corporate Summary
    Table 49. AbbiVie Injectable Targeted Therapy Product Offerings
    Table 50. AbbiVie Injectable Targeted Therapy Revenue (US$, Mn), (2017-2022)
    Table 51. AstraZeneca Corporate Summary
    Table 52. AstraZeneca Injectable Targeted Therapy Product Offerings
    Table 53. AstraZeneca Injectable Targeted Therapy Revenue (US$, Mn), (2017-2022)
    Table 54. Teva Corporate Summary
    Table 55. Teva Injectable Targeted Therapy Product Offerings
    Table 56. Teva Injectable Targeted Therapy Revenue (US$, Mn), (2017-2022)
    Table 57. Roche Corporate Summary
    Table 58. Roche Injectable Targeted Therapy Product Offerings
    Table 59. Roche Injectable Targeted Therapy Revenue (US$, Mn), (2017-2022)
    Table 60. Pfizer Corporate Summary
    Table 61. Pfizer Injectable Targeted Therapy Product Offerings
    Table 62. Pfizer Injectable Targeted Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Injectable Targeted Therapy Segment by Type in 2021
    Figure 2. Injectable Targeted Therapy Segment by Application in 2021
    Figure 3. Global Injectable Targeted Therapy Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Injectable Targeted Therapy Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Injectable Targeted Therapy Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Injectable Targeted Therapy Revenue in 2021
    Figure 8. By Type - Global Injectable Targeted Therapy Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Injectable Targeted Therapy Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Injectable Targeted Therapy Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Injectable Targeted Therapy Revenue Market Share, 2017-2028
    Figure 12. US Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Injectable Targeted Therapy Revenue Market Share, 2017-2028
    Figure 16. Germany Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2028
    Figure 17. France Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Injectable Targeted Therapy Revenue Market Share, 2017-2028
    Figure 24. China Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2028
    Figure 28. India Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Injectable Targeted Therapy Revenue Market Share, 2017-2028
    Figure 30. Brazil Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Injectable Targeted Therapy Revenue Market Share, 2017-2028
    Figure 33. Turkey Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Injectable Targeted Therapy Revenue, (US$, Mn), 2017-2028
    Figure 37. Novartis Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Sanofi Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. GSK Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Bayer Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Amgen Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Merck Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. AbbiVie Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. AstraZeneca Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Teva Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Roche Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Pfizer Injectable Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
63
Frequently Asked Questions
Injectable Targeted Therapy Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Injectable Targeted Therapy Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Injectable Targeted Therapy Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports